Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 2% below Graham Number — thin margin of safety
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 13.1% — below-average profitability
- Revenue growing at 11% annually
The Cigna Group (CI) is a Financial Services company operating in Hospital & Medical Service Plans, listed on the NYSE , with a market capitalisation of $70.4 billion . Key value metrics: P/E ratio 12.9, P/B ratio 1.69, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
The Cigna Group — Fundamental Analysis Summary
The Cigna Group (CI) is trading 2% below its Graham Number of $271.69, offering a thin margin of safety. The stock carries a reasonable trailing P/E ratio of 12.9x.
On financial health, CI shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 13.1% (sector average: 5.8%), and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for CI is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CI reports a moderate gross margin of 23.1% (sector average: 9.2%) and a modest operating margin of 3.5%.
CI shows revenue growing at 11% year-over-year, with earnings growing at 73%.
CI pays a modest dividend yield of 2.2%.